Disulfidptosis-related lncRNA signature to assess the immune microenvironment and drug sensitivity in acute myeloid leukemia
Abstract Acute myeloid leukemia (AML) represents a hematological malignancy that arises from the abnormal proliferation of progenitor cells or myeloid hematopoietic stem. The current standard treatments for AML include chemotherapy and hematopoietic stem cell transplantation. However, chemotherapy s...
Saved in:
Main Authors: | Yuying Zhao, Hai-en Cheng, Jingfei Wang, Yunke Zang, Zhijun Liu, Yanhua Sun, Yanli Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-12-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-024-83560-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expression and clinical significance of disulfidptosis-related LncRNA in gastric cancer
by: CHU Yudan, SUN Haidong, CUI Ran, ZHENG Hong
Published: (2024-09-01) -
Hemophagocytic lymphohistiocytosis secondary to refractory acute myeloid leukemia resolved after second line treatment with azacitidine plus venetoclax
by: Claudio Fozza
Published: (2024-01-01) -
Comprehensive analysis of disulfidptosis-related genes and the immune microenvironment in heart failure
by: Linna Zhao, et al.
Published: (2025-01-01) -
Impact of Hemoglobin, Leucocyte and Thrombocyte Levels at Diagnosis on the Survival Outcomes of Chronic Myeloid Leukemia Patients
by: Taha Ulutan Kars, et al.
Published: (2024-02-01) -
6-month survival of patients with acute myeloid leukemia who received modified chemotherapy at Wahidin Sudirohusodo Hospital
by: Edwinda D. Ratu, et al.
Published: (2024-09-01)